

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 4.02342365 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.02342365 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 3.70652480 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.70652480 |
| 5 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 3.64563358 |
| 6 | fatty acid homeostasis (GO:0055089) | 3.63304045 |
| 7 | phosphatidylethanolamine metabolic process (GO:0046337) | 3.40337777 |
| 8 | negative regulation of cholesterol transport (GO:0032375) | 3.34980414 |
| 9 | negative regulation of sterol transport (GO:0032372) | 3.34980414 |
| 10 | drug catabolic process (GO:0042737) | 3.29235152 |
| 11 | bile acid biosynthetic process (GO:0006699) | 3.25902561 |
| 12 | carnitine shuttle (GO:0006853) | 3.23047037 |
| 13 | alpha-linolenic acid metabolic process (GO:0036109) | 3.20749632 |
| 14 | ncRNA 3-end processing (GO:0043628) | 3.14099529 |
| 15 | fatty acid transmembrane transport (GO:1902001) | 3.13691802 |
| 16 | aromatic amino acid family catabolic process (GO:0009074) | 3.05631598 |
| 17 | positive regulation of glycolytic process (GO:0045821) | 3.02794547 |
| 18 | regulation of G0 to G1 transition (GO:0070316) | 2.98467443 |
| 19 | protein carboxylation (GO:0018214) | 2.94230409 |
| 20 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.94230409 |
| 21 | glyoxylate metabolic process (GO:0046487) | 2.90636420 |
| 22 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.81456288 |
| 23 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.79739222 |
| 24 | sulfur amino acid catabolic process (GO:0000098) | 2.78665720 |
| 25 | negative regulation of heart rate (GO:0010459) | 2.76897789 |
| 26 | bile acid metabolic process (GO:0008206) | 2.73140346 |
| 27 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.72103057 |
| 28 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.71593847 |
| 29 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.70813214 |
| 30 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.70813214 |
| 31 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.68633826 |
| 32 | glycine transport (GO:0015816) | 2.67957418 |
| 33 | synaptic vesicle maturation (GO:0016188) | 2.64830536 |
| 34 | regulation of energy homeostasis (GO:2000505) | 2.62188624 |
| 35 | glutamate secretion (GO:0014047) | 2.61960249 |
| 36 | inositol phosphate dephosphorylation (GO:0046855) | 2.61011958 |
| 37 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.61011958 |
| 38 | flavonoid metabolic process (GO:0009812) | 2.60990178 |
| 39 | gamma-aminobutyric acid transport (GO:0015812) | 2.58128621 |
| 40 | complement activation, alternative pathway (GO:0006957) | 2.57618518 |
| 41 | synaptic vesicle exocytosis (GO:0016079) | 2.56422702 |
| 42 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.56113930 |
| 43 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.55529251 |
| 44 | response to muscle activity (GO:0014850) | 2.53164763 |
| 45 | inositol phosphate catabolic process (GO:0071545) | 2.53001127 |
| 46 | cellular ketone body metabolic process (GO:0046950) | 2.52583709 |
| 47 | negative regulation of lipid catabolic process (GO:0050995) | 2.51293403 |
| 48 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.51248767 |
| 49 | detection of molecule of bacterial origin (GO:0032490) | 2.51086994 |
| 50 | high-density lipoprotein particle remodeling (GO:0034375) | 2.49518823 |
| 51 | negative regulation of cell killing (GO:0031342) | 2.46123966 |
| 52 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.46123966 |
| 53 | cysteine metabolic process (GO:0006534) | 2.45952583 |
| 54 | negative regulation of lipase activity (GO:0060192) | 2.45794056 |
| 55 | glutamate metabolic process (GO:0006536) | 2.44259578 |
| 56 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.43550213 |
| 57 | multicellular organism reproduction (GO:0032504) | 2.43387151 |
| 58 | omega-hydroxylase P450 pathway (GO:0097267) | 2.42677820 |
| 59 | regulation of synapse structural plasticity (GO:0051823) | 2.42011308 |
| 60 | exogenous drug catabolic process (GO:0042738) | 2.41443562 |
| 61 | positive regulation by symbiont of host defense response (GO:0052509) | 2.40909039 |
| 62 | modulation by symbiont of host defense response (GO:0052031) | 2.40909039 |
| 63 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.40909039 |
| 64 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.40909039 |
| 65 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.40909039 |
| 66 | modulation by symbiont of host immune response (GO:0052553) | 2.40909039 |
| 67 | postsynaptic membrane organization (GO:0001941) | 2.39572223 |
| 68 | carnitine transmembrane transport (GO:1902603) | 2.39163691 |
| 69 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.37037193 |
| 70 | drug metabolic process (GO:0017144) | 2.36767434 |
| 71 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.35599455 |
| 72 | negative regulation of interleukin-1 production (GO:0032692) | 2.34324919 |
| 73 | tryptophan catabolic process (GO:0006569) | 2.32274583 |
| 74 | indole-containing compound catabolic process (GO:0042436) | 2.32274583 |
| 75 | indolalkylamine catabolic process (GO:0046218) | 2.32274583 |
| 76 | coenzyme catabolic process (GO:0009109) | 2.31765252 |
| 77 | intracellular lipid transport (GO:0032365) | 2.31466566 |
| 78 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.30890463 |
| 79 | regulation of cholesterol esterification (GO:0010872) | 2.30791382 |
| 80 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.30220819 |
| 81 | regulation of protein activation cascade (GO:2000257) | 2.30082993 |
| 82 | negative regulation of appetite (GO:0032099) | 2.29519979 |
| 83 | negative regulation of response to food (GO:0032096) | 2.29519979 |
| 84 | fatty acid elongation (GO:0030497) | 2.28557864 |
| 85 | plasma lipoprotein particle clearance (GO:0034381) | 2.28407532 |
| 86 | neurotransmitter secretion (GO:0007269) | 2.28364390 |
| 87 | glycosylceramide metabolic process (GO:0006677) | 2.28116251 |
| 88 | kynurenine metabolic process (GO:0070189) | 2.27863151 |
| 89 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.27794343 |
| 90 | fibrinolysis (GO:0042730) | 2.27790974 |
| 91 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.27470836 |
| 92 | reverse cholesterol transport (GO:0043691) | 2.27341884 |
| 93 | urea cycle (GO:0000050) | 2.27138804 |
| 94 | urea metabolic process (GO:0019627) | 2.27138804 |
| 95 | regulation of triglyceride metabolic process (GO:0090207) | 2.26362667 |
| 96 | tryptophan metabolic process (GO:0006568) | 2.26348506 |
| 97 | cholesterol efflux (GO:0033344) | 2.25961466 |
| 98 | L-amino acid import (GO:0043092) | 2.25775084 |
| 99 | amino-acid betaine transport (GO:0015838) | 2.25423762 |
| 100 | carnitine transport (GO:0015879) | 2.25423762 |
| 101 | vocalization behavior (GO:0071625) | 2.25258950 |
| 102 | purine nucleotide transport (GO:0015865) | 2.25257436 |
| 103 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.25105778 |
| 104 | positive regulation of humoral immune response (GO:0002922) | 2.25030159 |
| 105 | very long-chain fatty acid metabolic process (GO:0000038) | 2.24720044 |
| 106 | response to dietary excess (GO:0002021) | 2.24470205 |
| 107 | cellular glucuronidation (GO:0052695) | 2.24430248 |
| 108 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.24346211 |
| 109 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.23452119 |
| 110 | melanin biosynthetic process (GO:0042438) | 2.23114473 |
| 111 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.22544288 |
| 112 | protein-lipid complex remodeling (GO:0034368) | 2.22505750 |
| 113 | macromolecular complex remodeling (GO:0034367) | 2.22505750 |
| 114 | plasma lipoprotein particle remodeling (GO:0034369) | 2.22505750 |
| 115 | protein import into peroxisome matrix (GO:0016558) | 2.22304579 |
| 116 | microglial cell activation (GO:0001774) | 2.21636362 |
| 117 | macroautophagy (GO:0016236) | 2.21375913 |
| 118 | cofactor catabolic process (GO:0051187) | 2.21249922 |
| 119 | short-chain fatty acid metabolic process (GO:0046459) | 2.21091534 |
| 120 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.20586129 |
| 121 | macrophage activation involved in immune response (GO:0002281) | 2.20190971 |
| 122 | xenobiotic catabolic process (GO:0042178) | 2.20021322 |
| 123 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.19907460 |
| 124 | regulation of fibrinolysis (GO:0051917) | 2.19899922 |
| 125 | phospholipid homeostasis (GO:0055091) | 2.19724117 |
| 126 | relaxation of smooth muscle (GO:0044557) | 2.19658895 |
| 127 | regulation of complement activation (GO:0030449) | 2.19319185 |
| 128 | type I interferon signaling pathway (GO:0060337) | 2.19114199 |
| 129 | cellular response to type I interferon (GO:0071357) | 2.19114199 |
| 130 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.18205132 |
| 131 | uronic acid metabolic process (GO:0006063) | 2.18186790 |
| 132 | glucuronate metabolic process (GO:0019585) | 2.18186790 |
| 133 | cellular modified amino acid catabolic process (GO:0042219) | 2.18034388 |
| 134 | low-density lipoprotein particle remodeling (GO:0034374) | 2.17607667 |
| 135 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.17588293 |
| 136 | response to type I interferon (GO:0034340) | 2.17566080 |
| 137 | pyrimidine-containing compound salvage (GO:0008655) | 2.16926042 |
| 138 | pyrimidine nucleoside salvage (GO:0043097) | 2.16926042 |
| 139 | regulation of triglyceride catabolic process (GO:0010896) | 2.16892618 |
| 140 | neutrophil mediated immunity (GO:0002446) | 2.16665547 |
| 141 | phosphatidylcholine biosynthetic process (GO:0006656) | 2.16336823 |
| 142 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.15858923 |
| 143 | negative regulation of fibrinolysis (GO:0051918) | 2.15665891 |
| 144 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.15562452 |
| 145 | cholesterol homeostasis (GO:0042632) | 2.14106140 |
| 146 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.13315503 |
| 147 | phospholipid efflux (GO:0033700) | 2.13013862 |
| 148 | nitrogen cycle metabolic process (GO:0071941) | 2.12972844 |
| 149 | thioester biosynthetic process (GO:0035384) | 2.12899933 |
| 150 | acyl-CoA biosynthetic process (GO:0071616) | 2.12899933 |
| 151 | ketone body metabolic process (GO:1902224) | 2.12276865 |
| 152 | polyol catabolic process (GO:0046174) | 2.11785540 |
| 153 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.11254066 |
| 154 | sterol homeostasis (GO:0055092) | 2.10769388 |
| 155 | acylglycerol homeostasis (GO:0055090) | 2.10607495 |
| 156 | triglyceride homeostasis (GO:0070328) | 2.10607495 |
| 157 | succinate metabolic process (GO:0006105) | 2.10600914 |
| 158 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.10570768 |
| 159 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.10461002 |
| 160 | cellular extravasation (GO:0045123) | 2.09205771 |
| 161 | acute inflammatory response (GO:0002526) | 2.09010062 |
| 162 | NADH metabolic process (GO:0006734) | 2.08219539 |
| 163 | pyrimidine dimer repair (GO:0006290) | 2.07833067 |
| 164 | negative regulation of Ras GTPase activity (GO:0034261) | 2.07440102 |
| 165 | regulation of sensory perception of pain (GO:0051930) | 2.05240506 |
| 166 | regulation of sensory perception (GO:0051931) | 2.05240506 |
| 167 | regulation of acrosome reaction (GO:0060046) | 2.05140758 |
| 168 | negative regulation of protein activation cascade (GO:2000258) | 2.04701931 |
| 169 | negative regulation of smooth muscle contraction (GO:0045986) | 2.04101113 |
| 170 | positive regulation of coagulation (GO:0050820) | 2.03112548 |
| 171 | positive regulation of hemostasis (GO:1900048) | 2.02402172 |
| 172 | positive regulation of blood coagulation (GO:0030194) | 2.02402172 |
| 173 | primary alcohol catabolic process (GO:0034310) | 2.01294026 |
| 174 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.00907573 |
| 175 | membrane tubulation (GO:0097320) | 2.00578702 |
| 176 | activated T cell proliferation (GO:0050798) | 1.99914025 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.14084335 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.01074070 |
| 3 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.77100845 |
| 4 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.56207359 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.53188304 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.50612256 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.47170369 |
| 8 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.95936403 |
| 9 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.91228165 |
| 10 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.85691170 |
| 11 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.82634952 |
| 12 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.80317458 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.73568721 |
| 14 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.73093653 |
| 15 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.70509819 |
| 16 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.67919369 |
| 17 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.65848965 |
| 18 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.62450883 |
| 19 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.61549334 |
| 20 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.59461395 |
| 21 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.55582241 |
| 22 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.54156004 |
| 23 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.48430484 |
| 24 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.45038273 |
| 25 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.45038273 |
| 26 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.44643358 |
| 27 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.44128162 |
| 28 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.37429360 |
| 29 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.36972355 |
| 30 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.36408882 |
| 31 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.34948428 |
| 32 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34693954 |
| 33 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.34642707 |
| 34 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.34495994 |
| 35 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.33895589 |
| 36 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.31917497 |
| 37 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.31026680 |
| 38 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.29449178 |
| 39 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.28341880 |
| 40 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.28272982 |
| 41 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.27713050 |
| 42 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.27394279 |
| 43 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.25645667 |
| 44 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.23193082 |
| 45 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.23193082 |
| 46 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.22570186 |
| 47 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.22065740 |
| 48 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.20829888 |
| 49 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.19669569 |
| 50 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.18455453 |
| 51 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.17778433 |
| 52 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.15805803 |
| 53 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.14562596 |
| 54 | GATA1_22025678_ChIP-Seq_K562_Human | 1.14036383 |
| 55 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.13824459 |
| 56 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.13507846 |
| 57 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.13292406 |
| 58 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.12782795 |
| 59 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11829048 |
| 60 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10947008 |
| 61 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.09646252 |
| 62 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.09171014 |
| 63 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.09064391 |
| 64 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.08159115 |
| 65 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.06547265 |
| 66 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.06513123 |
| 67 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.05994195 |
| 68 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.05812866 |
| 69 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.04210972 |
| 70 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03870955 |
| 71 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.03136622 |
| 72 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02117957 |
| 73 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.02028857 |
| 74 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.01203113 |
| 75 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.00666858 |
| 76 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00634611 |
| 77 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.99790667 |
| 78 | CJUN_26792858_Chip-Seq_BT549_Human | 0.99104891 |
| 79 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.98863924 |
| 80 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96794550 |
| 81 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.96431005 |
| 82 | RXR_22108803_ChIP-Seq_LS180_Human | 0.95967491 |
| 83 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.95478766 |
| 84 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.95103695 |
| 85 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.94733283 |
| 86 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.93547089 |
| 87 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.93521174 |
| 88 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.93198641 |
| 89 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.93042795 |
| 90 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.92728865 |
| 91 | ERA_21632823_ChIP-Seq_H3396_Human | 0.92345848 |
| 92 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91413695 |
| 93 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.89834108 |
| 94 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.89636544 |
| 95 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.89454488 |
| 96 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.89158755 |
| 97 | AR_25329375_ChIP-Seq_VCAP_Human | 0.88921647 |
| 98 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.88822191 |
| 99 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.88624839 |
| 100 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.88428222 |
| 101 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.88181800 |
| 102 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.87666730 |
| 103 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.87493087 |
| 104 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.86812000 |
| 105 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.86671037 |
| 106 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.86021858 |
| 107 | SPI1_23127762_ChIP-Seq_K562_Human | 0.85982165 |
| 108 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.85518656 |
| 109 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.83512429 |
| 110 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.82928430 |
| 111 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.82916423 |
| 112 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.82822085 |
| 113 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.82589125 |
| 114 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.82321287 |
| 115 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.82251617 |
| 116 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.82169431 |
| 117 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.81949056 |
| 118 | TP53_16413492_ChIP-PET_HCT116_Human | 0.81902125 |
| 119 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.81608002 |
| 120 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.81100717 |
| 121 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.80074620 |
| 122 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79580060 |
| 123 | * NANOG_20526341_ChIP-Seq_ESCs_Human | 0.79497498 |
| 124 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.79205268 |
| 125 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.78991109 |
| 126 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.78990753 |
| 127 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.78082356 |
| 128 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.77776297 |
| 129 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.77756474 |
| 130 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.77639486 |
| 131 | STAT3_23295773_ChIP-Seq_U87_Human | 0.77121000 |
| 132 | GATA1_19941826_ChIP-Seq_K562_Human | 0.76557708 |
| 133 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.76519821 |
| 134 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.76201273 |
| 135 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.75884842 |
| 136 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.75834791 |
| 137 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.75821810 |
| 138 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.75614547 |
| 139 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.75351262 |
| 140 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.75100293 |
| 141 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.73831226 |
| 142 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.73645465 |
| 143 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.73276978 |
| 144 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.72368534 |
| 145 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.72362371 |
| 146 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72272336 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.59455871 |
| 2 | MP0005085_abnormal_gallbladder_physiolo | 3.46953122 |
| 3 | MP0005360_urolithiasis | 3.42763814 |
| 4 | MP0005365_abnormal_bile_salt | 3.24417868 |
| 5 | MP0005058_abnormal_lysosome_morphology | 2.82670109 |
| 6 | MP0004859_abnormal_synaptic_plasticity | 2.76324309 |
| 7 | MP0003724_increased_susceptibility_to | 2.61856788 |
| 8 | MP0000015_abnormal_ear_pigmentation | 2.53274220 |
| 9 | MP0002909_abnormal_adrenal_gland | 2.50173063 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 2.43508483 |
| 11 | MP0010368_abnormal_lymphatic_system | 2.38680349 |
| 12 | MP0009840_abnormal_foam_cell | 2.38261077 |
| 13 | MP0003690_abnormal_glial_cell | 2.29489103 |
| 14 | MP0004130_abnormal_muscle_cell | 2.28797068 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.22836161 |
| 16 | MP0004270_analgesia | 2.15797748 |
| 17 | MP0010329_abnormal_lipoprotein_level | 2.08529827 |
| 18 | MP0009780_abnormal_chondrocyte_physiolo | 2.02555803 |
| 19 | MP0003329_amyloid_beta_deposits | 2.02086431 |
| 20 | MP0003195_calcinosis | 1.99640917 |
| 21 | MP0009764_decreased_sensitivity_to | 1.97095585 |
| 22 | MP0002090_abnormal_vision | 1.93983293 |
| 23 | MP0003075_altered_response_to | 1.93904951 |
| 24 | MP0003252_abnormal_bile_duct | 1.91399658 |
| 25 | MP0005083_abnormal_biliary_tract | 1.87906548 |
| 26 | MP0000604_amyloidosis | 1.87536307 |
| 27 | MP0003635_abnormal_synaptic_transmissio | 1.82922649 |
| 28 | MP0001666_abnormal_nutrient_absorption | 1.81824484 |
| 29 | MP0005451_abnormal_body_composition | 1.80499105 |
| 30 | MP0002064_seizures | 1.74470769 |
| 31 | MP0004043_abnormal_pH_regulation | 1.73179033 |
| 32 | MP0002118_abnormal_lipid_homeostasis | 1.72371294 |
| 33 | MP0009785_altered_susceptibility_to | 1.61418525 |
| 34 | MP0001727_abnormal_embryo_implantation | 1.58821825 |
| 35 | MP0003172_abnormal_lysosome_physiology | 1.58323502 |
| 36 | MP0003880_abnormal_central_pattern | 1.57661544 |
| 37 | MP0005332_abnormal_amino_acid | 1.57312227 |
| 38 | MP0001533_abnormal_skeleton_physiology | 1.56440089 |
| 39 | MP0003436_decreased_susceptibility_to | 1.55941198 |
| 40 | MP0000372_irregular_coat_pigmentation | 1.55092538 |
| 41 | MP0009745_abnormal_behavioral_response | 1.49790084 |
| 42 | MP0010386_abnormal_urinary_bladder | 1.48610393 |
| 43 | MP0001501_abnormal_sleep_pattern | 1.46561197 |
| 44 | MP0000920_abnormal_myelination | 1.45951788 |
| 45 | MP0001764_abnormal_homeostasis | 1.43630470 |
| 46 | MP0002419_abnormal_innate_immunity | 1.40813933 |
| 47 | MP0005174_abnormal_tail_pigmentation | 1.39431497 |
| 48 | MP0001873_stomach_inflammation | 1.38723530 |
| 49 | MP0009046_muscle_twitch | 1.36910541 |
| 50 | MP0002063_abnormal_learning/memory/cond | 1.36698063 |
| 51 | MP0003633_abnormal_nervous_system | 1.36633054 |
| 52 | MP0001851_eye_inflammation | 1.34726086 |
| 53 | MP0002837_dystrophic_cardiac_calcinosis | 1.32713468 |
| 54 | MP0001486_abnormal_startle_reflex | 1.30627966 |
| 55 | MP0004858_abnormal_nervous_system | 1.30396801 |
| 56 | MP0001986_abnormal_taste_sensitivity | 1.28571662 |
| 57 | MP0005535_abnormal_body_temperature | 1.28558014 |
| 58 | MP0002734_abnormal_mechanical_nocicepti | 1.27336922 |
| 59 | MP0001968_abnormal_touch/_nociception | 1.25034544 |
| 60 | MP0000609_abnormal_liver_physiology | 1.23400236 |
| 61 | MP0003868_abnormal_feces_composition | 1.22324171 |
| 62 | MP0002272_abnormal_nervous_system | 1.21967168 |
| 63 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.21047426 |
| 64 | MP0002572_abnormal_emotion/affect_behav | 1.20468250 |
| 65 | MP0000343_altered_response_to | 1.19549946 |
| 66 | MP0002736_abnormal_nociception_after | 1.17716927 |
| 67 | MP0002822_catalepsy | 1.16771301 |
| 68 | MP0000371_diluted_coat_color | 1.15335535 |
| 69 | MP0003879_abnormal_hair_cell | 1.14982419 |
| 70 | MP0004883_abnormal_blood_vessel | 1.12770901 |
| 71 | MP0003631_nervous_system_phenotype | 1.10801837 |
| 72 | MP0003183_abnormal_peptide_metabolism | 1.10488562 |
| 73 | MP0005167_abnormal_blood-brain_barrier | 1.09482968 |
| 74 | MP0006082_CNS_inflammation | 1.09373768 |
| 75 | MP0005646_abnormal_pituitary_gland | 1.09072673 |
| 76 | MP0002876_abnormal_thyroid_physiology | 1.09044638 |
| 77 | MP0003806_abnormal_nucleotide_metabolis | 1.09035017 |
| 78 | MP0009643_abnormal_urine_homeostasis | 1.07675721 |
| 79 | MP0002078_abnormal_glucose_homeostasis | 1.04061968 |
| 80 | MP0002168_other_aberrant_phenotype | 1.02379049 |
| 81 | MP0005551_abnormal_eye_electrophysiolog | 1.02137706 |
| 82 | MP0008260_abnormal_autophagy | 1.01392043 |
| 83 | MP0008874_decreased_physiological_sensi | 1.00199895 |
| 84 | MP0002933_joint_inflammation | 0.99329142 |
| 85 | MP0002229_neurodegeneration | 0.98988806 |
| 86 | MP0003646_muscle_fatigue | 0.98582976 |
| 87 | MP0002693_abnormal_pancreas_physiology | 0.97058377 |
| 88 | MP0005166_decreased_susceptibility_to | 0.96163317 |
| 89 | MP0002148_abnormal_hypersensitivity_rea | 0.95919630 |
| 90 | MP0004019_abnormal_vitamin_homeostasis | 0.95339821 |
| 91 | MP0003632_abnormal_nervous_system | 0.95255750 |
| 92 | MP0000013_abnormal_adipose_tissue | 0.94220195 |
| 93 | MP0003300_gastrointestinal_ulcer | 0.92650004 |
| 94 | MP0004885_abnormal_endolymph | 0.91373542 |
| 95 | MP0005386_behavior/neurological_phenoty | 0.91263387 |
| 96 | MP0004924_abnormal_behavior | 0.91263387 |
| 97 | MP0003634_abnormal_glial_cell | 0.91120801 |
| 98 | MP0005025_abnormal_response_to | 0.90827652 |
| 99 | MP0005075_abnormal_melanosome_morpholog | 0.90621084 |
| 100 | MP0005390_skeleton_phenotype | 0.90553808 |
| 101 | MP0004484_altered_response_of | 0.89534678 |
| 102 | MP0005319_abnormal_enzyme/_coenzyme | 0.88650893 |
| 103 | MP0002998_abnormal_bone_remodeling | 0.87989626 |
| 104 | MP0005448_abnormal_energy_balance | 0.87289997 |
| 105 | MP0002067_abnormal_sensory_capabilities | 0.85493062 |
| 106 | MP0004036_abnormal_muscle_relaxation | 0.85475319 |
| 107 | MP0001970_abnormal_pain_threshold | 0.85162362 |
| 108 | MP0005595_abnormal_vascular_smooth | 0.84750159 |
| 109 | MP0005409_darkened_coat_color | 0.84549139 |
| 110 | MP0005387_immune_system_phenotype | 0.84483155 |
| 111 | MP0001790_abnormal_immune_system | 0.84483155 |
| 112 | MP0002295_abnormal_pulmonary_circulatio | 0.84436571 |
| 113 | MP0002138_abnormal_hepatobiliary_system | 0.84021123 |
| 114 | MP0005171_absent_coat_pigmentation | 0.83783407 |
| 115 | MP0006276_abnormal_autonomic_nervous | 0.83295399 |
| 116 | MP0002733_abnormal_thermal_nociception | 0.82055220 |
| 117 | MP0000569_abnormal_digit_pigmentation | 0.80937654 |
| 118 | MP0004510_myositis | 0.80854326 |
| 119 | MP0005334_abnormal_fat_pad | 0.80464167 |
| 120 | MP0008438_abnormal_cutaneous_collagen | 0.80296586 |
| 121 | MP0003303_peritoneal_inflammation | 0.80217746 |
| 122 | MP0004185_abnormal_adipocyte_glucose | 0.79808992 |
| 123 | MP0001905_abnormal_dopamine_level | 0.79228727 |
| 124 | MP0003136_yellow_coat_color | 0.78393680 |
| 125 | MP0001502_abnormal_circadian_rhythm | 0.77272196 |
| 126 | MP0003045_fibrosis | 0.77090313 |
| 127 | MP0001440_abnormal_grooming_behavior | 0.77029398 |
| 128 | MP0001800_abnormal_humoral_immune | 0.76219975 |
| 129 | MP0004142_abnormal_muscle_tone | 0.76101705 |
| 130 | MP0008569_lethality_at_weaning | 0.75781302 |
| 131 | MP0009765_abnormal_xenobiotic_induced | 0.74566857 |
| 132 | MP0000230_abnormal_systemic_arterial | 0.74233679 |
| 133 | MP0009115_abnormal_fat_cell | 0.74220141 |
| 134 | MP0003656_abnormal_erythrocyte_physiolo | 0.73924197 |
| 135 | MP0008469_abnormal_protein_level | 0.73718742 |
| 136 | MP0001765_abnormal_ion_homeostasis | 0.73468476 |
| 137 | MP0005464_abnormal_platelet_physiology | 0.73136795 |
| 138 | MP0003953_abnormal_hormone_level | 0.72326046 |
| 139 | MP0004742_abnormal_vestibular_system | 0.71948064 |
| 140 | MP0002066_abnormal_motor_capabilities/c | 0.71698604 |
| 141 | MP0002735_abnormal_chemical_nociception | 0.70805180 |
| 142 | MP0005164_abnormal_response_to | 0.70697158 |
| 143 | MP0005410_abnormal_fertilization | 0.70169813 |
| 144 | MP0001915_intracranial_hemorrhage | 0.69300606 |
| 145 | MP0002723_abnormal_immune_serum | 0.67897960 |
| 146 | MP0000685_abnormal_immune_system | 0.65938465 |
| 147 | MP0005647_abnormal_sex_gland | 0.65732341 |
| 148 | MP0005376_homeostasis/metabolism_phenot | 0.65699222 |
| 149 | MP0005000_abnormal_immune_tolerance | 0.65636353 |
| 150 | MP0000767_abnormal_smooth_muscle | 0.65433143 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Striae distensae (HP:0001065) | 6.03067146 |
| 2 | Metaphyseal cupping (HP:0003021) | 4.66992879 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.57779559 |
| 4 | Cupped ribs (HP:0000887) | 4.49949122 |
| 5 | Abnormality of macular pigmentation (HP:0008002) | 4.19260799 |
| 6 | Constricted visual fields (HP:0001133) | 4.15709862 |
| 7 | Round ear (HP:0100830) | 4.01257401 |
| 8 | Cone-rod dystrophy (HP:0000548) | 3.99438233 |
| 9 | Toxemia of pregnancy (HP:0100603) | 3.87372812 |
| 10 | Ovoid vertebral bodies (HP:0003300) | 3.86390288 |
| 11 | Deep venous thrombosis (HP:0002625) | 3.81258436 |
| 12 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.78564115 |
| 13 | Complement deficiency (HP:0004431) | 3.73368702 |
| 14 | Neurofibrillary tangles (HP:0002185) | 3.59751703 |
| 15 | Intrahepatic cholestasis (HP:0001406) | 3.59422709 |
| 16 | Increased cerebral lipofuscin (HP:0011813) | 3.57498160 |
| 17 | Focal motor seizures (HP:0011153) | 3.54920822 |
| 18 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.31443075 |
| 19 | Attenuation of retinal blood vessels (HP:0007843) | 3.29924357 |
| 20 | Supranuclear gaze palsy (HP:0000605) | 3.28855863 |
| 21 | Prolonged partial thromboplastin time (HP:0003645) | 3.10145957 |
| 22 | Visual hallucinations (HP:0002367) | 3.06433849 |
| 23 | Tibial bowing (HP:0002982) | 3.00820807 |
| 24 | Systemic lupus erythematosus (HP:0002725) | 2.99107776 |
| 25 | Cerebral inclusion bodies (HP:0100314) | 2.97604477 |
| 26 | Axonal loss (HP:0003447) | 2.95811152 |
| 27 | Dysostosis multiplex (HP:0000943) | 2.89527422 |
| 28 | Hyperventilation (HP:0002883) | 2.88899295 |
| 29 | Orchitis (HP:0100796) | 2.77825202 |
| 30 | Myokymia (HP:0002411) | 2.76517067 |
| 31 | Gingival bleeding (HP:0000225) | 2.76004909 |
| 32 | Xanthomatosis (HP:0000991) | 2.74803231 |
| 33 | Glomerulonephritis (HP:0000099) | 2.73100308 |
| 34 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.64263417 |
| 35 | Generalized tonic-clonic seizures (HP:0002069) | 2.63911384 |
| 36 | Ocular albinism (HP:0001107) | 2.60495165 |
| 37 | Coxa vara (HP:0002812) | 2.57264513 |
| 38 | Epidermoid cyst (HP:0200040) | 2.54402665 |
| 39 | Action tremor (HP:0002345) | 2.53489214 |
| 40 | Sensorimotor neuropathy (HP:0007141) | 2.51741504 |
| 41 | Ketosis (HP:0001946) | 2.49822442 |
| 42 | Abnormality of the common coagulation pathway (HP:0010990) | 2.47742128 |
| 43 | Myositis (HP:0100614) | 2.47187739 |
| 44 | Hematochezia (HP:0002573) | 2.47118457 |
| 45 | Cerebral hemorrhage (HP:0001342) | 2.45252364 |
| 46 | Epileptic encephalopathy (HP:0200134) | 2.45230445 |
| 47 | Decreased muscle mass (HP:0003199) | 2.44059663 |
| 48 | Abnormality of complement system (HP:0005339) | 2.43739174 |
| 49 | Large earlobe (HP:0009748) | 2.43552643 |
| 50 | Focal seizures (HP:0007359) | 2.43296383 |
| 51 | Abnormal gallbladder morphology (HP:0012437) | 2.41619089 |
| 52 | Hyperlipoproteinemia (HP:0010980) | 2.40985458 |
| 53 | Conjugated hyperbilirubinemia (HP:0002908) | 2.40505071 |
| 54 | Hypoglycemic coma (HP:0001325) | 2.39344018 |
| 55 | Albinism (HP:0001022) | 2.39099645 |
| 56 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.38404680 |
| 57 | Mucopolysacchariduria (HP:0008155) | 2.38404680 |
| 58 | Femoral bowing (HP:0002980) | 2.38043297 |
| 59 | Vacuolated lymphocytes (HP:0001922) | 2.36990909 |
| 60 | Hypochromic microcytic anemia (HP:0004840) | 2.36128036 |
| 61 | Oligodontia (HP:0000677) | 2.34858640 |
| 62 | Congenital stationary night blindness (HP:0007642) | 2.31964530 |
| 63 | Retrobulbar optic neuritis (HP:0100654) | 2.31016084 |
| 64 | Optic neuritis (HP:0100653) | 2.31016084 |
| 65 | Joint hemorrhage (HP:0005261) | 2.30597261 |
| 66 | Pheochromocytoma (HP:0002666) | 2.30017264 |
| 67 | Amyloidosis (HP:0011034) | 2.29851210 |
| 68 | Cholelithiasis (HP:0001081) | 2.29447084 |
| 69 | Colitis (HP:0002583) | 2.28540581 |
| 70 | Progressive neurologic deterioration (HP:0002344) | 2.28488700 |
| 71 | Peritonitis (HP:0002586) | 2.27837270 |
| 72 | Generalized hypopigmentation (HP:0007513) | 2.27552580 |
| 73 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.25477324 |
| 74 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.25255159 |
| 75 | Widely spaced teeth (HP:0000687) | 2.23729897 |
| 76 | Iris hypopigmentation (HP:0007730) | 2.20906174 |
| 77 | Hypoglycemic seizures (HP:0002173) | 2.19320707 |
| 78 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.18147837 |
| 79 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.18147837 |
| 80 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.18147837 |
| 81 | Mesangial abnormality (HP:0001966) | 2.18146890 |
| 82 | Stomatitis (HP:0010280) | 2.17828166 |
| 83 | Status epilepticus (HP:0002133) | 2.17199361 |
| 84 | Congenital sensorineural hearing impairment (HP:0008527) | 2.15143175 |
| 85 | Spastic tetraparesis (HP:0001285) | 2.15053121 |
| 86 | Hypobetalipoproteinemia (HP:0003563) | 2.14476565 |
| 87 | Hyperammonemia (HP:0001987) | 2.13727168 |
| 88 | Inability to walk (HP:0002540) | 2.12974309 |
| 89 | Cholecystitis (HP:0001082) | 2.11270846 |
| 90 | Abnormal gallbladder physiology (HP:0012438) | 2.11270846 |
| 91 | Lack of skin elasticity (HP:0100679) | 2.11202140 |
| 92 | Generalized myoclonic seizures (HP:0002123) | 2.11178537 |
| 93 | Spontaneous abortion (HP:0005268) | 2.10227700 |
| 94 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.08825958 |
| 95 | Abnormality of the intrinsic pathway (HP:0010989) | 2.08052990 |
| 96 | Retinal atrophy (HP:0001105) | 2.07797927 |
| 97 | Fat malabsorption (HP:0002630) | 2.05553139 |
| 98 | Delayed CNS myelination (HP:0002188) | 2.05534948 |
| 99 | Absence seizures (HP:0002121) | 2.05273865 |
| 100 | Volvulus (HP:0002580) | 2.04084062 |
| 101 | Abnormality of macrophages (HP:0004311) | 2.01643714 |
| 102 | Skin nodule (HP:0200036) | 2.01563409 |
| 103 | Irritability (HP:0000737) | 2.00852079 |
| 104 | Metabolic alkalosis (HP:0200114) | 2.00531111 |
| 105 | Abnormality of methionine metabolism (HP:0010901) | 2.00339547 |
| 106 | Mutism (HP:0002300) | 2.00102556 |
| 107 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.99467023 |
| 108 | Ulnar claw (HP:0001178) | 1.99040176 |
| 109 | Generalized aminoaciduria (HP:0002909) | 1.98663022 |
| 110 | Ketoacidosis (HP:0001993) | 1.97336310 |
| 111 | Dialeptic seizures (HP:0011146) | 1.96547160 |
| 112 | Large for gestational age (HP:0001520) | 1.96200908 |
| 113 | Hypochromic anemia (HP:0001931) | 1.95957877 |
| 114 | Abnormality of glycolipid metabolism (HP:0010969) | 1.95659553 |
| 115 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.95659553 |
| 116 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.95659553 |
| 117 | Hypoalphalipoproteinemia (HP:0003233) | 1.95231526 |
| 118 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.95105329 |
| 119 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.94738236 |
| 120 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.94263190 |
| 121 | Prominent supraorbital ridges (HP:0000336) | 1.92689079 |
| 122 | Neuronal loss in central nervous system (HP:0002529) | 1.91654200 |
| 123 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.90653994 |
| 124 | Neuroendocrine neoplasm (HP:0100634) | 1.89601308 |
| 125 | J-shaped sella turcica (HP:0002680) | 1.89562708 |
| 126 | Intention tremor (HP:0002080) | 1.88326861 |
| 127 | Vascular calcification (HP:0004934) | 1.87865116 |
| 128 | Hypolipoproteinemia (HP:0010981) | 1.86942159 |
| 129 | Decreased circulating renin level (HP:0003351) | 1.86807036 |
| 130 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.85567313 |
| 131 | Mitral stenosis (HP:0001718) | 1.85554874 |
| 132 | Postural instability (HP:0002172) | 1.85226206 |
| 133 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.83938848 |
| 134 | Spastic paraparesis (HP:0002313) | 1.83096814 |
| 135 | Hyperbilirubinemia (HP:0002904) | 1.82788405 |
| 136 | Broad nasal tip (HP:0000455) | 1.82606483 |
| 137 | Abnormality of the gallbladder (HP:0005264) | 1.82233297 |
| 138 | Dysdiadochokinesis (HP:0002075) | 1.81319610 |
| 139 | Atonic seizures (HP:0010819) | 1.81110754 |
| 140 | Brushfield spots (HP:0001088) | 1.80831719 |
| 141 | Symptomatic seizures (HP:0011145) | 1.80569811 |
| 142 | Intellectual disability, progressive (HP:0006887) | 1.78847222 |
| 143 | Alkalosis (HP:0001948) | 1.78767739 |
| 144 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.77011121 |
| 145 | Dicarboxylic aciduria (HP:0003215) | 1.77011121 |
| 146 | Absent speech (HP:0001344) | 1.76374956 |
| 147 | Pulmonary embolism (HP:0002204) | 1.73442995 |
| 148 | Dysmetria (HP:0001310) | 1.73036783 |
| 149 | Nephritis (HP:0000123) | 1.73021705 |
| 150 | Choroideremia (HP:0001139) | 1.71511026 |
| 151 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.70949700 |
| 152 | Lymphedema (HP:0001004) | 1.70432785 |
| 153 | Prolonged neonatal jaundice (HP:0006579) | 1.69013828 |
| 154 | Disproportionate short-trunk short stature (HP:0003521) | 1.68959982 |
| 155 | Recurrent abscess formation (HP:0002722) | 1.68848423 |
| 156 | Generalized hypopigmentation of hair (HP:0011358) | 1.68767156 |
| 157 | Acne (HP:0001061) | 1.66741415 |
| 158 | Progressive inability to walk (HP:0002505) | 1.64094865 |
| 159 | Photophobia (HP:0000613) | 1.62591693 |
| 160 | Recurrent bacterial skin infections (HP:0005406) | 1.61559137 |
| 161 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.59990503 |
| 162 | Hypoplastic ischia (HP:0003175) | 1.59594742 |
| 163 | Intellectual disability, severe (HP:0010864) | 1.57760004 |
| 164 | Amelogenesis imperfecta (HP:0000705) | 1.57486611 |
| 165 | Progressive visual loss (HP:0000529) | 1.56561085 |
| 166 | Hemiplegia (HP:0002301) | 1.56148381 |
| 167 | Freckling (HP:0001480) | 1.56098074 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LATS1 | 3.14481068 |
| 2 | SIK2 | 3.14207796 |
| 3 | ZAK | 3.02572646 |
| 4 | CAMKK2 | 2.82292378 |
| 5 | ARAF | 2.76089705 |
| 6 | MAP3K9 | 2.72598224 |
| 7 | CAMK1D | 2.56358494 |
| 8 | MAP3K7 | 2.37519022 |
| 9 | RIPK4 | 2.36323633 |
| 10 | CAMKK1 | 2.24661098 |
| 11 | KSR2 | 2.21489338 |
| 12 | NTRK1 | 2.12131535 |
| 13 | CAMK1G | 1.93606754 |
| 14 | ERN1 | 1.86679418 |
| 15 | TNK2 | 1.83632037 |
| 16 | SCYL2 | 1.77450685 |
| 17 | MST4 | 1.75989359 |
| 18 | NTRK3 | 1.71293952 |
| 19 | PAK6 | 1.68344494 |
| 20 | BCKDK | 1.66760777 |
| 21 | STK11 | 1.62707882 |
| 22 | PRKD3 | 1.59771334 |
| 23 | LMTK2 | 1.51829968 |
| 24 | STK38 | 1.49809583 |
| 25 | DAPK2 | 1.44980309 |
| 26 | TEC | 1.42061488 |
| 27 | MAP3K3 | 1.36732750 |
| 28 | ADRBK1 | 1.34595192 |
| 29 | EPHB1 | 1.33166057 |
| 30 | MET | 1.32263217 |
| 31 | IKBKB | 1.29457404 |
| 32 | CSK | 1.27811703 |
| 33 | MAP3K13 | 1.26594773 |
| 34 | PINK1 | 1.26200146 |
| 35 | OXSR1 | 1.23606205 |
| 36 | MAP4K1 | 1.23223677 |
| 37 | JAK1 | 1.22955143 |
| 38 | MAP2K3 | 1.22901057 |
| 39 | ZAP70 | 1.22107739 |
| 40 | INSRR | 1.21610333 |
| 41 | MST1R | 1.20265216 |
| 42 | MAP3K4 | 1.19827863 |
| 43 | MAPK13 | 1.19821825 |
| 44 | EPHB2 | 1.17061839 |
| 45 | ACVR1B | 1.16998717 |
| 46 | TAOK3 | 1.15952547 |
| 47 | PRKAA2 | 1.15819613 |
| 48 | MAP3K2 | 1.14186757 |
| 49 | PDK2 | 1.11947890 |
| 50 | PRKCH | 1.09984639 |
| 51 | EPHA4 | 1.09319978 |
| 52 | NUAK1 | 1.08742271 |
| 53 | EPHA3 | 1.07574327 |
| 54 | MAPKAPK5 | 1.07521260 |
| 55 | SIK3 | 1.06468710 |
| 56 | PTK6 | 1.04416749 |
| 57 | FRK | 1.02708370 |
| 58 | PDPK1 | 1.01962676 |
| 59 | KSR1 | 1.01377251 |
| 60 | MAP3K10 | 1.00349170 |
| 61 | MAP2K4 | 0.99139803 |
| 62 | IRAK4 | 0.97576088 |
| 63 | FES | 0.97511629 |
| 64 | TYK2 | 0.97310654 |
| 65 | FGFR2 | 0.96810551 |
| 66 | MARK3 | 0.96042443 |
| 67 | CDK19 | 0.95220832 |
| 68 | MAP2K7 | 0.94994031 |
| 69 | TRIB3 | 0.94522379 |
| 70 | JAK2 | 0.93801508 |
| 71 | MUSK | 0.93176302 |
| 72 | FGFR4 | 0.92447449 |
| 73 | CDK5 | 0.90455639 |
| 74 | TBK1 | 0.89727762 |
| 75 | TGFBR2 | 0.88140956 |
| 76 | GRK1 | 0.88030679 |
| 77 | PRPF4B | 0.87946947 |
| 78 | IKBKE | 0.86703913 |
| 79 | CASK | 0.86595114 |
| 80 | PAK3 | 0.85787826 |
| 81 | SYK | 0.85149157 |
| 82 | TESK2 | 0.85086129 |
| 83 | SGK223 | 0.84361121 |
| 84 | SGK494 | 0.84361121 |
| 85 | RAF1 | 0.83342343 |
| 86 | NTRK2 | 0.82297821 |
| 87 | PDK1 | 0.81553401 |
| 88 | CSF1R | 0.81088852 |
| 89 | MAP3K11 | 0.79855784 |
| 90 | PRKG2 | 0.79227184 |
| 91 | STK39 | 0.78885437 |
| 92 | TXK | 0.78343572 |
| 93 | MAP3K6 | 0.78310356 |
| 94 | MAPK12 | 0.77502123 |
| 95 | TAOK1 | 0.77292498 |
| 96 | GRK6 | 0.76140588 |
| 97 | MINK1 | 0.75877729 |
| 98 | MAP2K6 | 0.75805949 |
| 99 | ERBB4 | 0.74534502 |
| 100 | MARK1 | 0.74329001 |
| 101 | TESK1 | 0.72889023 |
| 102 | CAMK4 | 0.71841904 |
| 103 | RET | 0.71127430 |
| 104 | PTK2B | 0.70999971 |
| 105 | SIK1 | 0.70899819 |
| 106 | JAK3 | 0.69547757 |
| 107 | MAP2K1 | 0.68389946 |
| 108 | PRKD2 | 0.68358863 |
| 109 | CAMK2G | 0.65631511 |
| 110 | ADRBK2 | 0.64622391 |
| 111 | PRKAA1 | 0.64343453 |
| 112 | PRKACG | 0.63681779 |
| 113 | RPS6KA2 | 0.62379698 |
| 114 | MAP3K1 | 0.61997064 |
| 115 | LIMK1 | 0.61778803 |
| 116 | MAP4K2 | 0.61752011 |
| 117 | TYRO3 | 0.61102268 |
| 118 | DYRK1B | 0.60951655 |
| 119 | ABL2 | 0.60287722 |
| 120 | FGR | 0.56756882 |
| 121 | PRKCZ | 0.56707795 |
| 122 | MYLK | 0.56285674 |
| 123 | BLK | 0.56165043 |
| 124 | BRAF | 0.56022411 |
| 125 | CAMK2A | 0.56020714 |
| 126 | SGK3 | 0.55829226 |
| 127 | MARK2 | 0.55068584 |
| 128 | PRKD1 | 0.54760840 |
| 129 | KIT | 0.52838821 |
| 130 | MOS | 0.51998037 |
| 131 | FER | 0.50864934 |
| 132 | CAMK2B | 0.49942138 |
| 133 | HCK | 0.49331627 |
| 134 | CAMK1 | 0.49177210 |
| 135 | GRK5 | 0.49026333 |
| 136 | NEK2 | 0.48127783 |
| 137 | PHKG1 | 0.47753906 |
| 138 | PHKG2 | 0.47753906 |
| 139 | CHUK | 0.47426174 |
| 140 | RPS6KB1 | 0.46884777 |
| 141 | HIPK2 | 0.46703174 |
| 142 | PRKCE | 0.46416146 |
| 143 | DYRK2 | 0.45478275 |
| 144 | PRKCG | 0.44944878 |
| 145 | FYN | 0.44861714 |
| 146 | AKT3 | 0.44757958 |
| 147 | WNK3 | 0.43345026 |
| 148 | CDC42BPA | 0.43251424 |
| 149 | DAPK3 | 0.43154461 |
| 150 | PDGFRB | 0.42762122 |
| 151 | IRAK1 | 0.42687384 |
| 152 | MAPKAPK3 | 0.42452266 |
| 153 | WNK1 | 0.41435754 |
| 154 | TAOK2 | 0.40506102 |
| 155 | CSNK1G2 | 0.40271545 |
| 156 | SGK1 | 0.36487136 |
| 157 | PKN1 | 0.36325448 |
| 158 | PRKCQ | 0.35544784 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.11496052 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.04268111 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.14860135 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.10964255 |
| 5 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.95796849 |
| 6 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.88386265 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.87952682 |
| 8 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.72765502 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.67980532 |
| 10 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.64605443 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.63962726 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.60319760 |
| 13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.51122851 |
| 14 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.50537007 |
| 15 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.47419652 |
| 16 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.46617930 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.44253964 |
| 18 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.42653585 |
| 19 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.40637407 |
| 20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.35324429 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.33874871 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.32357212 |
| 23 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.31190244 |
| 24 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.30479048 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.29946992 |
| 26 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.29605461 |
| 27 | Bile secretion_Homo sapiens_hsa04976 | 1.20845417 |
| 28 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.19101469 |
| 29 | Peroxisome_Homo sapiens_hsa04146 | 1.16953449 |
| 30 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.15769046 |
| 31 | Lysosome_Homo sapiens_hsa04142 | 1.15438912 |
| 32 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.14108138 |
| 33 | Phototransduction_Homo sapiens_hsa04744 | 1.12239256 |
| 34 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.11121823 |
| 35 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.04511316 |
| 36 | GABAergic synapse_Homo sapiens_hsa04727 | 1.03762979 |
| 37 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.03160300 |
| 38 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.02076382 |
| 39 | Insulin secretion_Homo sapiens_hsa04911 | 0.99555703 |
| 40 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.98674791 |
| 41 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.97998332 |
| 42 | ABC transporters_Homo sapiens_hsa02010 | 0.95157693 |
| 43 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.93355773 |
| 44 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.92946247 |
| 45 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.92051080 |
| 46 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.91331682 |
| 47 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.90032288 |
| 48 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.88981128 |
| 49 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.88671628 |
| 50 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.87624848 |
| 51 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.87566664 |
| 52 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.86952510 |
| 53 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.86697722 |
| 54 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.86599641 |
| 55 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.83981811 |
| 56 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.83961261 |
| 57 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.83872841 |
| 58 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.83757620 |
| 59 | Pertussis_Homo sapiens_hsa05133 | 0.82363244 |
| 60 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.81756245 |
| 61 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.80491274 |
| 62 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.77995933 |
| 63 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.76524953 |
| 64 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.76435683 |
| 65 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.76392726 |
| 66 | Malaria_Homo sapiens_hsa05144 | 0.76379099 |
| 67 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.75696636 |
| 68 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.75511060 |
| 69 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.75324888 |
| 70 | Prion diseases_Homo sapiens_hsa05020 | 0.73759250 |
| 71 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.73049683 |
| 72 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.72974465 |
| 73 | Morphine addiction_Homo sapiens_hsa05032 | 0.72625267 |
| 74 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.72056679 |
| 75 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.71053379 |
| 76 | Retinol metabolism_Homo sapiens_hsa00830 | 0.70393161 |
| 77 | Cocaine addiction_Homo sapiens_hsa05030 | 0.70181657 |
| 78 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.69403394 |
| 79 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.68536654 |
| 80 | Circadian entrainment_Homo sapiens_hsa04713 | 0.68443996 |
| 81 | Salivary secretion_Homo sapiens_hsa04970 | 0.67411974 |
| 82 | Nicotine addiction_Homo sapiens_hsa05033 | 0.66908056 |
| 83 | Long-term potentiation_Homo sapiens_hsa04720 | 0.66395712 |
| 84 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.65198337 |
| 85 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.63541552 |
| 86 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.63370256 |
| 87 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.63283115 |
| 88 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.62817172 |
| 89 | Olfactory transduction_Homo sapiens_hsa04740 | 0.61930114 |
| 90 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.61903807 |
| 91 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.61515147 |
| 92 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.61093007 |
| 93 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.60919605 |
| 94 | Renin secretion_Homo sapiens_hsa04924 | 0.60464885 |
| 95 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.60014159 |
| 96 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.58834027 |
| 97 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.58675700 |
| 98 | Taste transduction_Homo sapiens_hsa04742 | 0.58660745 |
| 99 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.56996936 |
| 100 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.56966526 |
| 101 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.55173262 |
| 102 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.54758460 |
| 103 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.53519201 |
| 104 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.53263343 |
| 105 | Carbon metabolism_Homo sapiens_hsa01200 | 0.52552043 |
| 106 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.52348248 |
| 107 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.52118385 |
| 108 | Other glycan degradation_Homo sapiens_hsa00511 | 0.51968036 |
| 109 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.51180292 |
| 110 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.50626933 |
| 111 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.50589900 |
| 112 | Hepatitis C_Homo sapiens_hsa05160 | 0.50408501 |
| 113 | Tuberculosis_Homo sapiens_hsa05152 | 0.49665920 |
| 114 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.49552931 |
| 115 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.49393760 |
| 116 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.49112268 |
| 117 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.48325442 |
| 118 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.47854480 |
| 119 | Measles_Homo sapiens_hsa05162 | 0.46940118 |
| 120 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.46016985 |
| 121 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.43850497 |
| 122 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.43017943 |
| 123 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.42505233 |
| 124 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.42347715 |
| 125 | Insulin resistance_Homo sapiens_hsa04931 | 0.41784158 |
| 126 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.41585451 |
| 127 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.40609549 |
| 128 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.40462155 |
| 129 | Phagosome_Homo sapiens_hsa04145 | 0.40438336 |
| 130 | Axon guidance_Homo sapiens_hsa04360 | 0.39742870 |
| 131 | Amoebiasis_Homo sapiens_hsa05146 | 0.39633804 |
| 132 | Shigellosis_Homo sapiens_hsa05131 | 0.39534883 |
| 133 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.39053195 |
| 134 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.38745803 |
| 135 | Mineral absorption_Homo sapiens_hsa04978 | 0.38310033 |
| 136 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.37720971 |
| 137 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.37702117 |
| 138 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.37580637 |
| 139 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.37386762 |
| 140 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.36490286 |
| 141 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.35810452 |
| 142 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.35689349 |
| 143 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.35675430 |
| 144 | Platelet activation_Homo sapiens_hsa04611 | 0.35248807 |
| 145 | Circadian rhythm_Homo sapiens_hsa04710 | 0.34720617 |

